by Ket Patel | Dec 21, 2018 | Uncategorized
Stroke is today one of the leading causes of death and, after dementia – often caused by a previous stroke – the 2nd leading cause of disability globally, and the burden of stroke is increasing.
by Ket Patel | Dec 21, 2018 | Uncategorized
Established by Boehringer Ingelheim in 2015, in collaboration with international stroke experts and the European Stroke Organisation (ESO), the Acute Networks StrivinG for ExceLlence in Stroke (ANGELS) project has had a major impact on expanding available treatment...
by Ket Patel | Dec 21, 2018 | Uncategorized
Technological innovations are optimizing endovascular treatment of patients with acute ischemic stroke (AIS) and cerebral aneurysms.
by Ket Patel | Dec 21, 2018 | Uncategorized
Endovascular treatment is the treatment of choice for many intracerebral aneurysms (ICAs). However, coiling is probably less effective for giant or wide-necked aneurysms, and retreatment is not uncommon. Flow diversion (FD) is a novel endovascular approach to ICA...
by Ket Patel | Aug 2, 2018 | Uncategorized
Non-vitamin-K oral anticoagulants (NOACs) have become the standard of care in stroke prevention for individuals with atrial fibrillation (AF).